This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Jul 10;50(2):146-8.

doi: 10.1016/j.jacc.2007.04.028. Epub 2007 May 22.

Drug-eluting stents is their future as bright as their past?

Adnan Kastrati, Albert Schömig

PMID: 17616298
DOI: 10.1016/j.jacc.2007.04.028

Free article

Editorial

Drug-eluting stents is their future as bright as their past?

Adnan Kastrati et al. J Am Coll Cardiol. 2007.

Free article

. 2007 Jul 10;50(2):146-8.

doi: 10.1016/j.jacc.2007.04.028. Epub 2007 May 22.

Authors

Adnan Kastrati, Albert Schömig

PMID: 17616298
DOI: 10.1016/j.jacc.2007.04.028

No abstract available

PubMed Disclaimer

Comment on

Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study.
Valgimigli M, Campo G, Arcozzi C, Malagutti P, Carletti R, Ferrari F, Barbieri D, Parrinello G, Percoco G, Ferrari R. Valgimigli M, et al. J Am Coll Cardiol. 2007 Jul 10;50(2):138-45. doi: 10.1016/j.jacc.2007.04.029. Epub 2007 May 22. J Am Coll Cardiol. 2007. PMID: 17616297 Clinical Trial.

Similar articles

Debating the risks of drug-eluting stents.
Shuchman M. Shuchman M. N Engl J Med. 2007 Jan 25;356(4):325-8. doi: 10.1056/NEJMp068300. N Engl J Med. 2007. PMID: 17251527 No abstract available.
Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents.
Bertrand OF, Faurie B, Larose E, Nguyen CM, Gleeton O, Déry JP, Noël B, Proulx G, Roy L, Costerousse O, De Larochellière R, Rodés-Cabau J. Bertrand OF, et al. J Invasive Cardiol. 2008 Mar;20(3):99-104. J Invasive Cardiol. 2008. PMID: 18316823
Coronary brachytherapy in the drug-eluting stent era: don't bury it alive.
Waksman R, Weinberger J. Waksman R, et al. Circulation. 2003 Jul 29;108(4):386-8. doi: 10.1161/01.CIR.0000082928.33891.B7. Circulation. 2003. PMID: 12885731 Review. No abstract available.
As time goes by: current status and future directions in the controversy over stenting.
Kaul S, Shah PK, Diamond GA. Kaul S, et al. J Am Coll Cardiol. 2007 Jul 10;50(2):128-37. doi: 10.1016/j.jacc.2007.04.030. Epub 2007 May 22. J Am Coll Cardiol. 2007. PMID: 17616296 Review.
Platelet glycoprotein IIb/IIIa receptor inhibitors: is their future as bright as their past?
Leesar MA. Leesar MA. Catheter Cardiovasc Interv. 2008 Jun 1;71(7):907-8. doi: 10.1002/ccd.21622. Catheter Cardiovasc Interv. 2008. PMID: 18498141 No abstract available.

See all similar articles

Cited by

Antiplatelet therapy in the era of late stent thrombosis.
Nair R, Simon DI. Nair R, et al. Curr Treat Options Cardiovasc Med. 2008 Feb;10(1):12-7. doi: 10.1007/s11936-008-0002-4. Curr Treat Options Cardiovasc Med. 2008. PMID: 18325303
Drug-eluting coronary stents: as safe as bare-metal stents, but optimized antiplatelet therapy may further improve clinical outcome.
Trenk D, Neumann FJ. Trenk D, et al. Eur J Clin Pharmacol. 2008 Mar;64(3):227-32. doi: 10.1007/s00228-007-0434-x. Epub 2007 Dec 13. Eur J Clin Pharmacol. 2008. PMID: 18075736 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal